Phase I trial evaluating MEK inhibitor selumetinib with concomitant thoracic radiotherapy in NSCLC

Kate Haslett; Fiona Blackhall; Pek Koh; Marie-Claude Asselin; Alan Jackson; Prakhash Manoharan; W David Ryder; B Taylor; Corinne Faivre-Finn

doi:10.1016/j.jtho.2017.09.620

Phase I trial evaluating MEK inhibitor selumetinib with concomitant thoracic radiotherapy in NSCLC

Kate Haslett, Fiona Blackhall, Pek Koh, Marie-Claude Asselin, Alan Jackson, Prakhash Manoharan, W David Ryder, B Taylor, Corinne Faivre-Finn

Research output: Chapter in Book/Report/Conference proceeding › Conference contribution › peer-review

Original language	English
Title of host publication	Radiotherapy and Oncology
Pages	S387-S387
Volume	127
DOIs	https://doi.org/10.1016/j.jtho.2017.09.620
Publication status	Published - 1 Apr 2018

Access to Document

10.1016/j.jtho.2017.09.620

Cite this

@inproceedings{ceced8d8e9204255a3a6ca0549d64760,

title = "Phase I trial evaluating MEK inhibitor selumetinib with concomitant thoracic radiotherapy in NSCLC",

author = "Kate Haslett and Fiona Blackhall and Pek Koh and Marie-Claude Asselin and Alan Jackson and Prakhash Manoharan and Ryder, {W David} and B Taylor and Corinne Faivre-Finn",

note = "Conference Conference: 37th Meeting of the European-Society-for-Radiotherapy-and-Oncology (ESTRO) Location: Barcelona, SPAIN Date: APR 20-24, 2018",

year = "2018",

month = apr,

day = "1",

doi = "10.1016/j.jtho.2017.09.620",

language = "English",

volume = "127",

pages = "S387--S387",

booktitle = "Radiotherapy and Oncology",

}

TY - GEN

T1 - Phase I trial evaluating MEK inhibitor selumetinib with concomitant thoracic radiotherapy in NSCLC

AU - Haslett, Kate

AU - Blackhall, Fiona

AU - Koh, Pek

AU - Asselin, Marie-Claude

AU - Jackson, Alan

AU - Manoharan, Prakhash

AU - Ryder, W David

AU - Taylor, B

AU - Faivre-Finn, Corinne

N1 - Conference Conference: 37th Meeting of the European-Society-for-Radiotherapy-and-Oncology (ESTRO) Location: Barcelona, SPAIN Date: APR 20-24, 2018

PY - 2018/4/1

Y1 - 2018/4/1

U2 - 10.1016/j.jtho.2017.09.620

DO - 10.1016/j.jtho.2017.09.620

M3 - Conference contribution

VL - 127

SP - S387-S387

BT - Radiotherapy and Oncology

ER -